PROPANC BIOPHARMA, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $5.5M | $95.1K | — |
| FY2018 | $6.8M | $71.4K | — |
| FY2019 | $4.4M | $101.7K | — |
| FY2020 | $3.7M | $98.5K | $67.0K |
| FY2021 | $3.1M | $13.1K | $2.3K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $5.5M | $95.1K | — |
| FY2018 | $6.8M | $71.4K | — |
| FY2019 | $4.4M | $101.7K | — |
| FY2020 | $3.7M | $98.5K | $67.0K |
| FY2021 | $3.1M | $13.1K | $2.3K |